2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

被引：0
|
作者：
N Ruperto
DJ Lovell
R Cuttica
P Woo
G Espada
C Wouters
ED Silverman
Z Balogh
M Henrickson
J Davidson
I Foeldvari
L Imundo
G Simonini
J Oppermann
YK Shen
S Visvanathan
A Fasanmade
A Mendelsohn
A Martini
EH Giannini
机构：
[1] IRCCS G Gaslini,
[2] Pediatria II – PRINTO,undefined
[3] Cincinnati Children's Hosp Med Center,undefined
[4] Hosp de Pediatria Dr Pedron de Elizalde,undefined
[5] Great Ormond St Hosp,undefined
[6] Hosp de Ninos Ricardo Gutierrez,undefined
[7] U Hosp Gathuisberg,undefined
[8] Hosp for Sick Children,undefined
[9] Royal Liverpool Childrens NHS Trust,undefined
[10] Eilbek Clinic,undefined
[11] Columbia/NY Presbyterian Hosp,undefined
[12] U Florence,undefined
[13] Kinderklinik,undefined
[14] Centocor R & D,undefined
[15] Inc,undefined
[16] National Inst Rheuma & Physiotherapy,undefined
[17] Children's Hospital,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Methotrexate; Infliximab; Juvenile Rheumatoid Arthritis; Core Variable; Active Arthritis;
D O I：
10.1186/1546-0096-6-S1-S3
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [22] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    [J]. Arthritis Research & Therapy, 21
  • [23] Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Jürgen Wollenhaupt
    Eun-Bong Lee
    Jeffrey R. Curtis
    Joel Silverfield
    Ketti Terry
    Koshika Soma
    Chris Mojcik
    Ryan DeMasi
    Sander Strengholt
    Kenneth Kwok
    Irina Lazariciu
    Lisy Wang
    Stanley Cohen
    [J]. Arthritis Research & Therapy, 21
  • [24] Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: 52 Week Safety and Efficacy in an Open-Label, Long-Term Extension Study
    Baker, Milton
    Chalabi, Youb
    Genovese, Mark
    Taylor, Peter
    Schlichting, Douglas
    Beattie, Scott
    Macias, William
    Keystone, Edward
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1505 - 1505
  • [25] Tofacitinib, An Oral Janus Kinase Inhibitor, In The Treatment Of Rheumatoid Arthritis: Open-Label, Long-Term Extension Safety and Efficacy Up To 5 Years
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Wood, Susan P.
    Terry, Ketti K.
    Nakamura, Hiroyuki
    Ohno, Yukako
    Gruben, David
    Benda, Birgitta
    Wang, Lisy
    Riese, Richard
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S993 - S993
  • [26] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Open-Label, Long-Term Extension Safety and Efficacy up to 48 Months
    Wollenhaupt, Jurgen
    Silverfield, Joel C.
    Lee, Eun Bong
    Wood, Susan P.
    Soma, Koshika
    Wang, Lisy
    Nakamura, Hiroyuki
    Komuro, Yoshihiro
    Nduaka, Chudi I.
    Gruben, David
    Benda, Birgitta
    Zwillich, Samuel H.
    Riese, Richard
    Bradley, John D.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S548 - S549
  • [27] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION UP TO 6 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Wood, S. P.
    Terry, K. K.
    Nakamura, H.
    Kwok, K.
    Anisfeld, A.
    Nduaka, C.
    Wang, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 259 - 259
  • [28] Long-term safety of methotrexate in the treatment of rheumatoid arthritis
    Yazici, Y.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S65 - S67
  • [29] THE EFFICACY AND SAFETY OF AURANOFIN IN THE TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS - A LONG-TERM OPEN STUDY
    MARCOLONGO, R
    MATHIEU, A
    PALA, R
    GIORDANO, N
    FIORAVANTI, A
    PANZARASA, R
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (08): : 979 - 983
  • [30] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8
    Pope, Janet
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Haraoui, Boulos
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 879 - 879
12345